22–23 Jul 2026
Heidelberg Congress Center
Europe/Berlin timezone

Effect of a supervised intermittent exercise program on insomnia in breast cancer patients undergoing chemotherapy

23 Jul 2026, 14:00
1h 15m
Heidelberg Congress Center ( Heidelberg Congress Center )

Heidelberg Congress Center

Heidelberg Congress Center

Czernyring 20 69115 Heidelberg Germany
1 - Scientific Poster Poster Session

Speaker

Chloé Drozd (Université de Haute-Alsace, LISEC (UR 2310), F-68200 Mulhouse, France)

Description

Background: Patients with localized breast cancer receiving (neo)adjuvant chemotherapy often experience sleep disturbances, especially insomnia, which significantly impacts quality of life. This study primarily aimed to evaluate the effects of a 12-week exercise program on insomnia, with secondary outcomes on sleep quality, anxiety/depression, fatigue, pain, and exercise adaptation.

Methods: In this randomized controlled multicenter trial, 20 women (mean age 46.8 years), with non-metastatic breast cancer and clinically diagnosed insomnia were assigned to a control (n=10) or training group (n=10). The training group underwent a 12-week supervised intermittent aerobic exercise program during chemotherapy. The primary outcome was objective total sleep time; secondary outcomes included insomnia severity, sleep architecture, sleep quality, anxiety/depression, fatigue, pain, and cardiorespiratory capacity. Assessments were performed before chemotherapy (T-1), at baseline (between the 1st and 2nd sequences of chemotherapy; T0), and post-intervention (3 months after; T3), using polysomnography, actigraphy, validated questionnaires, and a maximal graded exercise test.

Results: The prevalence of clinical insomnia, assessed according to DSM-5 criteria, increased from 47% before diagnosis to 71% at T-1, reaching 100% at T0. Total sleep time measured by polysomnography did not increase after training (07:16 at T0 to 06:13 at T3; p=0.97), although sleep fragmentation appeared to decrease. Based on the MFI-20 questionnaire, clinical improvement was observed in physical and activity-related fatigue. Finally, both submaximal exercise adaptation parameters (power and VO2/HR) and maximal parameters (power, VO2 peak, VO2/HR) significantly improved.

Conclusions: The supervised exercise program did not extend total sleep time in breast cancer patients undergoing chemotherapy, however, it may have enhanced sleep continuity, reduced certain dimensions of fatigue, and substantially improved physical fitness. Future research is needed to investigate the diverse etiologies of insomnia to develop tailored and personalized management approaches.

Keywords

Breast cancer, Insomnia, Sleep disorders, Exercise.

Abstract submitters declaration yes
Conflict of Interest & Ethical Approval yes

Author

Chloé Drozd (Université de Haute-Alsace, LISEC (UR 2310), F-68200 Mulhouse, France)

Co-authors

Prof. Elsa Curtit (Université Marie et Louis Pasteur, INSERM U1098 RIGHT, F-25000 Besançon, France) Dr Quentin Jacquinot (Université Marie et Louis Pasteur, SINERGIES, F-25000 Besançon, France) Dr Pauline Roux (Service de Physiologie – Explorations fonctionnelles, CHU Jean Minjoz, F-25000 Besançon, France) Dr Sophie Paget-Bailly (Université Marie et Louis Pasteur, INSERM U1098 RIGHT, F-25000 Besançon, France) Dr Valérie Gillet (Centre Médical Santé Sommeil - Ellipse, Association le Don Du Souffle, F-25000 Besançon, France) Dr Nathalie Meneveau (Institut Régional Fédératif du Cancer de Franche-Comté, F-25000 Besançon, France) Prof. Fabienne Mougin (Université Marie et Louis Pasteur, SINERGIES, F-25000 Besançon, France)

Presentation materials

There are no materials yet.